PMGC HOLDINGS INC. Related Party Transaction, Amounts of Transaction
PMGC HOLDINGS INC. (ELAB) reported Related Party Transaction, Amounts of Transaction of $182.76 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes
us-gaap:RelatedPartyTransactionAmountsOfTransaction · last filed 2026-08-14
- PMGC HOLDINGS INC. related party transaction, amounts of transaction for the quarter ending 2026-06-30 was $174.54K, a 1001.79% increase year-over-year.
- PMGC HOLDINGS INC. related party transaction, amounts of transaction for the quarter ending 2026-03-31 was $8.22K, a 60.45% decline year-over-year.
- PMGC HOLDINGS INC. related party transaction, amounts of transaction for the quarter ending 2025-12-31 was $10.66K, a 58.50% decline year-over-year.
- PMGC HOLDINGS INC. related party transaction, amounts of transaction for the quarter ending 2025-09-30 was $13.18K, a 57.16% decline year-over-year.
- PMGC HOLDINGS INC. related party transaction, amounts of transaction for fiscal 2025 was $60.45K, a 153.35% increase from fiscal 2024.
- PMGC HOLDINGS INC. related party transaction, amounts of transaction for fiscal 2024 was $23.86K, a 93.32% decline from fiscal 2023.
- PMGC HOLDINGS INC. related party transaction, amounts of transaction for fiscal 2023 was $357.35K.
| Period end | Related Party Transaction, Amounts of Transaction 3 month | Related Party Transaction, Amounts of Transaction 6 month | Related Party Transaction, Amounts of Transaction 9 month | Related Party Transaction, Amounts of Transaction 12 month |
|---|---|---|---|---|
| 2026-06-30 | $174.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $182.76K 10-Q · filed 2026-08-14 | $193.42K derived: sum of 3 quarters · filed 2026-08-14 | $206.60K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $8.22K 10-Q · filed 2026-05-15 | $18.87K derived: sum of 2 quarters · filed 2026-05-15 | $32.05K derived: sum of 3 quarters · filed 2026-05-15 | $47.90K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $10.66K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $23.84K derived: sum of 2 quarters · filed 2026-03-30 | $39.68K derived: sum of 3 quarters · filed 2026-08-14 | $60.45K 10-K · filed 2026-03-30 |
| 2025-09-30 | $13.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $29.02K derived: sum of 2 quarters · filed 2026-08-14 | $49.80K 10-Q · filed 2025-11-14 | $75.47K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $15.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $36.62K 10-Q · filed 2026-08-14 | $62.30K derived: sum of 3 quarters · filed 2026-08-14 | $93.06K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $20.77K 10-Q · filed 2026-05-15 | $46.45K derived: sum of 2 quarters · filed 2026-05-15 | $77.22K derived: sum of 3 quarters · filed 2026-05-15 | $22.36K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $25.68K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $56.44K derived: sum of 2 quarters · filed 2026-03-30 | $1.58K derived: sum of 3 quarters · filed 2026-03-30 | $23.86K 10-K · filed 2026-03-30 |
| 2024-09-30 | $30.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$24.09K derived: sum of 2 quarters · filed 2025-11-14 | -$1.82K 10-Q · filed 2025-11-14 | $210.01K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$54.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$32.58K 10-Q · filed 2025-08-13 | $179.25K derived: sum of 3 quarters · filed 2025-08-13 | $202.41K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $22.28K 10-Q · filed 2025-05-14 | $234.11K derived: sum of 2 quarters · filed 2025-05-14 | $257.27K derived: sum of 3 quarters · filed 2025-05-14 | $332.64K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $211.83K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $234.99K derived: sum of 2 quarters · filed 2025-03-28 | $310.36K derived: sum of 3 quarters · filed 2025-03-28 | $357.35K 10-K · filed 2025-03-28 |
| 2023-09-30 | $23.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $98.53K derived: sum of 2 quarters · filed 2024-11-14 | $145.52K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $75.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $122.36K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $46.99K 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |